Monday, November 9, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ASML Holding N.V. (ASML), Alibaba Group Holding Ltd. (BABA), Intuitive Surgical, Inc. (ISRG) as well as two micro-cap stocks, Paul Mueller Co. (MUEL) and Presurance Holdings, Inc. (PRHI). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Jensen Huang News Dominates Market Headlines

Today's Featured Research Reports

ASML’s shares have outperformed the Zacks Semiconductor Equipment - Wafer Fabrication industry over the past year (+37.2% vs. +35.3%). Per the Zacks analyst, the company benefits from strong AI-driven demand for advanced Logic and Memory capacity, rising lithography intensity and sustained demand for EUV, DUV and installed-base services. High-NA adoption further strengthens its technology leadership, while higher volumes, upgrades and improved product mix support profitability.

However, growth depends on sustained customer capital spending and successful production expansion. Export-control uncertainty surrounding China remains a risk, while the timing of broader High-NA adoption is still uncertain.

(You can read the full research report on ASML here >>>)

Alibaba’s shares have underperformed the Internet - Commerce industry over the last six months (-20.2% vs. -4.4%). The Zacks analyst believes that the company faces elevated investment requirements, slower China commerce monetization and continued spending on quick commerce and AI development. Heavy infrastructure outlays and uneven core-commerce trends constrain near-term returns.

Yet, its broad commerce ecosystem, growing AI-driven cloud demand and deeper consumer-platform integration offer attractive long-term growth opportunities. Better operating discipline and expanding AI applications further strengthen its prospects.

(You can read the full research report on Alibaba here >>>)

Intuitive Surgical’s shares have underperformed the Medical - Instruments  industry over the past year (-21.4% vs. +3.1%). The Zacks analyst believes that the company faces moderating U.S. procedure growth, weak bariatric volumes and intensifying competition and pricing pressures in China. Tariffs, product mix, hospital budget constraints and extended-use instruments could also weigh on margins and revenue growth.

However, its broad robotic platform, expanding installed base and recurring revenue model support durable growth. Adoption of Da Vinci 5, SP and Ion systems, healthy procedure demand and digital innovation strengthen its long-term prospects.

(You can read the full research report on Intuitive Surgical here >>>)

Paul Mueller’s shares have outperformed the Zacks Manufacturing - General Industrial industry over the past two years (+120.1% vs. -3.5%). The Zacks analyst believes that the company benefits from a sizable Industrial Equipment backlog, sustained demand and improving international contributions. Capacity expansion, modest leverage and continued shareholder returns further strengthen its investment case.

Yet, project mix, labor efficiency, contractor reliance and delivery schedules create execution risks. Rising working-capital needs, weaker cash conversion and exposure to dairy regulations and currency movements could constrain margin recovery.

(You can read the full research report on Paul Mueller here >>>)

Presurance’s shares have outperformed the Zacks Insurance - Multi Line industry over the last six months (+53.0% vs. +10.3%). The Zacks analyst believes that the company benefited from improved underwriting discipline and stronger profitability. Its strategic shift toward personal insurance and improved claims management have supported better operating performance, while strengthened capital resources have also aided.

However, the company’s business has contracted as it exits legacy commercial insurance lines, reducing premium volume. Cash outflows, regulatory capital constraints and a smaller operating scale remain concerns.

(You can read the full research report on Presurance here >>>)

Other noteworthy reports we are featuring today include Arista Networks, Inc. (ANET), Canadian Natural Resources Ltd. (CNQ) and Cintas Corp. (CTAS).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>